Zimbabwe has turned down a substantial US healthcare agreement worth $367m (272 million pounds) over five years due to the United States' request for confidential data.
This rejection came to light after a official document from December was disclosed, which showed President Emmerson Mnangagwa deemed the agreement was "lopsided".
A government spokesperson later stated that the US was demanding access to health data for research and commercial gain while refused to guarantee the benefits from future medical innovations.
"We will now turn to the challenging and unfortunate task of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had donated more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged continued negotiations to secure a deal acceptable to all parties so the country's critical HIV programme can continue.
Broader Context
This development follows a similar situation in Kenya, where a high court suspended a related deal with the US following concerns were filed about the safety of citizens' health data.
After returning to office last year, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
The agency had administered aid for the US government, but Trump stated its expenditure was "inefficient" and his administration was seeking direct bilateral agreements to boost transparency and responsibility.
According to reports, Sixteen African countries have to date agreed to similar agreements, representing over $18.3bn in new funding.
Details of the Declined Agreement
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this partnership might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through American-funded programmes," the Ambassador said.
However, official spokesman Nick Mangwana argued the proposed deal was "unfair".
"Zimbabwe was being asked to provide its biological resources and data for a long time, without any corresponding guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"Effectively, our country would supply the basic resources for scientific discovery with no assurance that the resulting innovations would be accessible to our population should a new health crisis emerge."
Sovereignty and Global Health
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were disrupting frameworks previously established via the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to deal with future global health emergencies.
"This mechanism is intended to guarantee that when a country contributes its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised solely by those with the funds to create them."
These objections over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We welcome continued discussions with our US partners on how subsequent collaboration might be structured in a way that honours the sovereignty and dignity of each country."
Medical Community Reaction
Medical experts expressed it acknowledged the government's concerns, but suggested that talks must proceed given that much of the nation's Aids initiatives were funded by international support.
"If technical issues arise, including those relating to information security or agreement terms, these can often be resolved through detailed discussion and mutually agreed protections," it commented.
This impasse highlights the continuing challenges between receiving crucial international aid and safeguarding national sovereignty in an increasingly interconnected world.